Literature DB >> 2095931

Nuclear polymorphism--a prognostic parameter to evaluate local recurrence of female breast cancer.

H R Rosen1, M Stierer, R Weber.   

Abstract

Between 1980 and 1986 676 patients underwent surgery for primary breast cancer. Of these, 35 patients developed locoregional recurrence. Retrospective analysis of the spontaneous postoperative development revealed 2 groups: group A had subsequent distant metastases, group B was tumor-free after surgical treatment of local recurrence. Analysis of the commonly employed characterization criteria of primary tumors (tumor size, lymph node involvement, estrogen receptors, histologic grading of primary tumors, and excised locoregional recurrence) showed no statistically significant difference between the two groups. However, a more detailed differentiation of the subcriteria for the histologic grading according to Bloom and Richardson revealed a prevalence of anaplastic nuclei in the primary tumors of group A (9/11). Even in this small patient population the parameter of nuclear polymorphism revealed a highly significant statistical difference between the two groups.

Entities:  

Mesh:

Year:  1990        PMID: 2095931     DOI: 10.1007/bf01812679

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  7 in total

1.  THE CLINICAL SIGNIFICANCE OF SKIN RECURRENCE AFTER RADICAL MASTECTOMY IN WOMEN WITH CANCER OF THE BREAST.

Authors:  T L DAO; T NEMOTO
Journal:  Surg Gynecol Obstet       Date:  1963-10

2.  Minimal breast cancer: a clinical appraisal.

Authors:  T G Peters; W L Donegan; E A Burg
Journal:  Ann Surg       Date:  1977-12       Impact factor: 12.969

3.  Emerging impact of flow cytometry in predicting recurrence and survival in breast cancer patients.

Authors:  W L McGuire; L G Dressler
Journal:  J Natl Cancer Inst       Date:  1985-09       Impact factor: 13.506

4.  Patterns of recurrent disease in breast cancer.

Authors:  J Bruce; D C Carter; J Fraser
Journal:  Lancet       Date:  1970-02-28       Impact factor: 79.321

5.  Adjuvant chemoimmunotherapy following regional therapy for isolated recurrences of breast cancer (stage IV NED).

Authors:  A U Buzdar; G R Blumenschein; T L Smith; C K Tashima; G N Hortobagyi; H Y Yap; J U Gutterman; E M Hersh; E A Gehan
Journal:  J Surg Oncol       Date:  1979       Impact factor: 3.454

6.  Local or regionally recurrent carcinoma of the breast: results of therapy in 121 patients.

Authors:  T M Beck; N E Hart; D A Woodard; C E Smith
Journal:  J Clin Oncol       Date:  1983-06       Impact factor: 44.544

7.  Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years.

Authors:  H J BLOOM; W W RICHARDSON
Journal:  Br J Cancer       Date:  1957-09       Impact factor: 7.640

  7 in total
  3 in total

1.  Placental isoferritin associated p43 antigen correlates with features of high differentiation in breast cancer.

Authors:  H R Rosen; C Moroz; A Reiner; M Reinerova; M Stierer; J Svec; M Schemper; R Jakesz
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

2.  Nuclear pleomorphism, a strong prognostic factor in axillary node-negative small invasive breast cancer.

Authors:  M Stierer; H Rosen; R Weber
Journal:  Breast Cancer Res Treat       Date:  1992-01       Impact factor: 4.872

3.  Immunohistochemical and biochemical measurement of estrogen and progesterone receptors in primary breast cancer. Correlation of histopathology and prognostic factors.

Authors:  M Stierer; H Rosen; R Weber; H Hanak; J Spona; H Tüchler
Journal:  Ann Surg       Date:  1993-07       Impact factor: 12.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.